Global Artificial Heart Lung Machines Competitive Landscape Professional Research Report 2024

Global Artificial Heart Lung Machines Competitive Landscape Professional Research Report 2024

Research Summary

Artificial Heart Lung Machines, also known as cardio-pulmonary bypass machines, are medical devices that temporarily take over the function of the heart and lungs during cardiac surgery. They are used to circulate and oxygenate the blood bypassing the heart and lungs while the heart is stopped to perform surgical procedures such as bypass grafts, valve replacements, heart transplants, and others. The machine pumps oxygenated blood from the lungs back into the body, allowing the heart to be stopped and repaired without causing severe organ damage. The use of artificial heart-lung machines has revolutionized cardiac surgery, enabling complex procedures to be performed safely.

According to DIResearch's in-depth investigation and research, the global Artificial Heart Lung Machines market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Artificial Heart Lung Machines include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Artificial Heart Lung Machines. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Heart Lung Machines market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Artificial Heart Lung Machines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Heart Lung Machines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Artificial Heart Lung Machines Include:

LivaNova (Sorin)

Getinge (Maquet)

Medtronic

Terumo CV Group

Braile Biomedica

Tianjin Medical

Artificial Heart Lung Machines Product Segment Include:

Single Roller Pump HLM

Double Roller Pump HLM

Artificial Heart Lung Machines Product Application Include:

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Artificial Heart Lung Machines Industry PESTEL Analysis

Chapter 3: Global Artificial Heart Lung Machines Industry Porter’s Five Forces Analysis

Chapter 4: Global Artificial Heart Lung Machines Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Artificial Heart Lung Machines Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Artificial Heart Lung Machines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Artificial Heart Lung Machines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Artificial Heart Lung Machines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Artificial Heart Lung Machines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Artificial Heart Lung Machines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Artificial Heart Lung Machines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Artificial Heart Lung Machines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources